KPIs & Operating Metrics(New)

Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Goodwill Amortization of Goodwill Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Cash from Restructuring Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Xylem (XYL) Capital Expenditures (2016 - 2026)

Xylem has reported Capital Expenditures over the past 17 years, most recently at $90.0 million for Q1 2026.

For Q1 2026, Capital Expenditures rose 26.76% year-over-year to $90.0 million; the TTM value through Mar 2026 reached $191.0 million, up 5.52%, while the annual FY2025 figure was $331.0 million, 3.12% up from the prior year.
Capital Expenditures for Q1 2026 was $90.0 million at Xylem, up from $83.0 million in the prior quarter.
Over five years, Capital Expenditures peaked at $100.0 million in Q4 2024 and troughed at $3.0 million in Q2 2024.
A 5-year average of $54.4 million and a median of $53.0 million in 2022 define the central range for Capital Expenditures.
Biggest five-year swings in Capital Expenditures: tumbled 94.34% in 2024 and later surged 266.67% in 2025.
Year by year, Capital Expenditures stood at $60.0 million in 2022, then skyrocketed by 56.67% to $94.0 million in 2023, then grew by 6.38% to $100.0 million in 2024, then fell by 17.0% to $83.0 million in 2025, then grew by 8.43% to $90.0 million in 2026.
Business Quant data shows Capital Expenditures for XYL at $90.0 million in Q1 2026, $83.0 million in Q4 2025, and $7.0 million in Q3 2025.